Abbott Laboratories' revenue and return on invested capital could be more consistent. Read why potential investors will need ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Abbott Laboratories (NYSE:ABT) is largely controlled by institutional shareholders who own 78% of the company Institutions' substantial holdings in Abbott Laboratories implies that they have ...

On Thursday, Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $117.26 which represents a slight increase of $1.33 or 1.15% from the prior close of $115.93. The stock opened at ...

Over half a decade, Abbott Laboratories managed to grow its earnings per share at 12% a year. The EPS growth is more ...

We recently compiled a list of the 8 Magnificent Dividend Growth Stocks to Buy Now. In this article, we are going to take a ...

On Thursday, Abbott Laboratories (ABT) stock saw a decline, ending the day at $115.03 which represents a decrease of $-0.71 or -0.61% from the prior close of $115.74. The stock opened at $115.98 and ...

With a market cap of $202.2 billion, North Chicago, Illinois-based Abbott Laboratories (ABT) is a global healthcare company.

Republican Texas Gov. Greg Abbott is demanding all agencies in the state halt investments in China and sell any current ...

Abbott (NYSE: ABT) today announced the first patient procedures with its investigational transcatheter aortic valve implantation (TAVI) balloon-expandable system for treating symptomatic severe aortic ...

Insulet Corp. (PODD), a provider of tubeless insulin pump technology, announced Wednesday that the Omnipod 5 Automated Insulin ...